Literature DB >> 2610690

Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.

F Libert1, A Lefort, C Gerard, M Parmentier, J Perret, M Ludgate, J E Dumont, G Vassart.   

Abstract

A human thyroid cDNA library was screened by hybridization with a dog thyrotropin receptor (TSHr) cDNA. Sequencing of the resulting clones identified a 2292 residue open reading frame encoding a 744 amino acid mature polypeptide presenting 90.3% similarity with the dog TSHr. Two major transcripts (4.6 and 4.4 kilobases) were identified in the human thyroid which suggests that alternative splicing could generate multiple forms of human TSHr. Transfection of the coding sequence in COS-7 cells conferred to a membrane preparation of these cells the ability to bind specifically TSH. TSH binding was completely displaced by immunoglobulin preparations from patients with idiopathic myxoedema.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610690     DOI: 10.1016/0006-291x(89)92736-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies.

Authors:  T Akamizu; S Ikuyama; M Saji; S Kosugi; C Kozak; O W McBride; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  The coexistence of a novel inactivating mutant thyrotropin receptor allele with two thyroid peroxidase mutations: a genotype-phenotype correlation.

Authors:  Chutintorn Sriphrapradang; Yardena Tenenbaum-Rakover; Mia Weiss; Marla S Barkoff; Osnat Admoni; Dallasheh Kawthar; Gianluigi Caltabiano; Leonardo Pardo; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

4.  Two-subunit structure of the human thyrotropin receptor.

Authors:  H Loosfelt; C Pichon; A Jolivet; M Misrahi; B Caillou; M Jamous; B Vannier; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 5.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

Review 6.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

7.  Intracellular cross-talk between thyrotropin receptor and A1 adenosine receptor in regulation of phospholipase C and adenylate cyclase in COS-7 cells transfected with their receptor genes.

Authors:  F Okajima; H Tomura; K Sho; M Akbar; M A Majid; Y Kondo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

8.  A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction.

Authors:  C P Tensen; E R Van Kesteren; R J Planta; K J Cox; J F Burke; H van Heerikhuizen; E Vreugdenhil
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells.

Authors:  S L Wu; T C Chang; T J Chang; Y F Kuo; Y L Hsiao; C C Chang
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 10.  Resistance to thyrotropin.

Authors:  S Refetoff
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.